Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-25-319291
Filing Date
2025-12-15
Accepted
2025-12-15 16:33:24
Documents
1
Period of Report
2025-12-11

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 16380
  Complete submission text file 0001193125-25-319291.txt   20738
Mailing Address BAKER BROS. ADVISORS LP 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Business Address
BAKER JULIAN (Reporting) CIK: 0001087939 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38311 | Film No.: 251572062

Mailing Address BAKER BROS. ADVISORS LP 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Business Address
BAKER FELIX (Reporting) CIK: 0001087940 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38311 | Film No.: 251572063

Mailing Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Business Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014 2123395600
BAKER BROS. ADVISORS LP (Reporting) CIK: 0001263508 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38311 | Film No.: 251572067

Mailing Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Business Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014 212-339-5600
Baker Brothers Life Sciences LP (Reporting) CIK: 0001363364 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38311 | Film No.: 251572064

Mailing Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Business Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014 212-339-5600
667, L.P. (Reporting) CIK: 0001551139 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38311 | Film No.: 251572066

Mailing Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Business Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014 (212)339-5600
Baker Bros. Advisors (GP) LLC (Reporting) CIK: 0001580575 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38311 | Film No.: 251572065

Mailing Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8547
Denali Therapeutics Inc. (Issuer) CIK: 0001714899 (see all company filings)

EIN.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)